Highlights: Immuron proceeding to Phase 3 registration strategy with the FDATravelan® topline clinical trial results demonstrate protective efficacy with single...
OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discoveryOGAP-Verify is now more...
Company is advancing mitochondriotropic therapeutic pipeline for rare neuromuscular disorders and neurodegenerative diseasesOXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE)...
BEIJING, March 7, 2024 /PRNewswire/ -- A report from Science and Technology Daily: Sci-tech innovation has not only boosted the competitiveness...
Technology Platform Has Been Granted Patents in Over 40 Countries Including -- United States, Canada and EuropePatents Include United States...
UPPSALA, SWEDEN / ACCESSWIRE / March 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in precision-based patient monitoring solutions,...
STOCKHOLM, SWEDEN / ACCESSWIRE / March 7, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...